Enriching knowledge and enhancing care through health data

Programme of the i~HD track @ Life Science Live

 

  Wednesday May 15, 2019

Opening ceremony and plenary keynote lecture

AI Imperatives for a Changing World

Andrew Fried
Global Life Sciences Industry Leader, IBM

Coffee break  

Getting the best value from health data - a multi-stakeholder prespective

Evidencing value based care through hospital EHRs and ICHOM standards

The hospital perspective

 

The pharma industry perspective

 

The patient perspective

 

Panel discussion


 

Thomas Allvin
EFPIA

Juuso Bloomster
University of Turku


Bart Vannieuwenhuyse
Janssen

Pieter van Galen
Belgium, Patient representative

Lunch at restaurant Messu/ Exhibition    

Plenary session:

How digital technologies will change the business


From laboratory to data, and from data to clinical value


Advancing personalized medicine from drug discovery through diagnosis

 

 

Kristoffer Miving
Digital lead, Nordics & Baltics, Janssen

Tommi Lehtonen
CEO, Blueprint Genetics Oy

Karen MAdden
Vice President of Technology and Innovation, PerkinElmer Inc.

Coffee Break/ Exhibition    

Essential enablers for scaling up the value of health data:


Measuring and improving data quality in hospitals

 


 

Complying with the GDPR when reusing real world data for research
 

Panel discussion

 

 



Pascal Coorevits
i~HD and University of Gent

Frank Staelens
OLV Hospital Aalst, Belgium

Filip De Meyer
University Hospital of Ghent
Saara Malkamäki, SITRA

Get-Together    
       

 

  Thursday May 16, 2019

Plenary keynote lecture with i~HD

The value of health data for Learning Health Systems

Dipak Kalra
President of i~HD

Innovative projects making great use of health data

Opening remarks
 

EHR2EDC
 

EHDEN
 

Trillium II and the International Patient Summary


Digital Health Europe

 

Dipak Kalra
President of i~HD

Nadir Ammour
Sanofi

Nigel Hughes
Janssen

Catherine Chronaki
HL7 Europe

Oliver Zobell
Jülich

Lunch at restaurant Festo/ Exhibition

pitching competition


 

Secondary use of clinical data in Finland, implementing a new law (EN)

 

 

Use of pharmacogenetic data in connection with personalized pharmaceutical treatment

Dipak Kalra
President of i~HD & chair

Petri Virolainen
Turku university hospital.

Jari Forström
Turku university hospital and Abomics Ltd

Public exhibition

Exhibition for Schools